» Researchers develop potent CDK9 inhibitor to overcome drug resistance in hematological malignancies
11/07/25 08:00 from Breaking World Pharma News
A research team led by Prof. LIU Qingsong and Prof. LIU Jing from the Hefei Institutes of Physical Science, Chinese Academy of Sciences, has recently developed a new class of compounds that effectively inhibit both wild-type CDK9 and its...

» Research opens up new avenue for tuberculosis drug discovery
10/07/25 08:00 from Breaking World Pharma News
A new study by University of Bath scientists has highlighted two new potential families of drug molecules that could open the door to new treatments for tuberculosis. Tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis,...

» Aggressive skin cancer driven by mitochondrial processes - existing drugs offer promising treatment path
09/07/25 08:00 from Breaking World Pharma News
A new study led by researchers at Lund University in Sweden, reveals that melanoma, the deadliest form of skin cancer, can in some cases be driven by mitochondrial processes, which can be effectively targeted using existing drugs. In pre...

» Study highlights major hurdles for multinational clinical trials in Europe
08/07/25 08:00 from Breaking World Pharma News
A new study by investigators from Europe, including the Netherlands and the United Kingdom (UK), has shed light on significant ethical, administrative, regulatory, and logistical (EARL) hurdles in delivering multinational randomized clin...

» New model to find treatments for an aggressive blood cancer
07/07/25 08:00 from Breaking World Pharma News
Researchers working on an incurable blood cancer can now use a new lab model which could make testing potential new treatments and diagnostics easier and quicker, new research has found. In a paper published in Nature Communications a te...

» Researchers identify new protein target to control chronic inflammation
04/07/25 08:00 from Breaking World Pharma News
Chronic inflammation occurs when the immune system is stuck in attack-mode, sending cell after cell to defend and repair the body for months or even years. Diseases associated with chronic inflammation, like arthritis or cancer or autoim...